Skip to content

Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)

Support Through Remote Observation and Nutrition Guidance Program for Individuals With Pancreatic Cancer Undergoing Surgery (STRONG-PCS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06001268
Acronym
STRONG-PCS
Enrollment
80
Registered
2023-08-21
Start date
2023-08-14
Completion date
2027-08-01
Last updated
2026-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Keywords

Nutrition Support

Brief summary

The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are undergoing surgery.

Interventions

Participants will log food intake while sharing their data with a dietician in real time for 12 weeks

BEHAVIORALNutrition Counseling

Participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth or in person.

BEHAVIORALSurvey

Participants will take a survey at baseline and weeks 4,8,\& 12. (FACT-G) Questionnaire includes questions about participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher total score indicates better quality of life.

Sponsors

H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER
United States Department of Defense
CollaboratorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years old * Diagnosis of pancreatic cancer * Completed open pancreatic surgery (e.g., Whipple, distal/subtotal pancreatectomy, total pancreatectomy) for treatment at Moffitt Cancer Center * Discharged on an oral diet * Able to speak and read English or Spanish * Able to provide informed consent

Exclusion criteria

* Determined to be ineligible for surgery during evaluation (e.g., cancer metastasis)

Design outcomes

Primary

MeasureTime frameDescription
Recruitment Rate - FeasibilityUp to 48 monthsThe study will be deemed feasible if ≥ 50% of eligible participants are enrolled.
Retention Rate - Feasibilityat 8 weeksThe study will be deemed feasible if ≥ 70% of participants enrolled at baseline will be retained at 8 weeks.
Data Collection - Feasibilityat 8 weeksThe study will be deemed feasible if ≥ 70% of participants log food for greater than 80% of study days.
Participant Satisfaction - Acceptabilityat 8 weeksThe study will be deemed acceptable if ≥ 70% of participants rate the overall intervention as satisfactory using a validated 4-item scale (score range 0-20, score \>/= 12).
Participant Rating on Ease of Use the Mobile Application - Usabilityat 8 weeksThe study will be deemed usable if ≥ 60% of participants rate the mobile application as easy-to-use for logging dietary intake using a validated 10-item scale (score range from 0-100, score of \>/=60).

Secondary

MeasureTime frameDescription
Malnutrition-Significant weight loss90 daysSignificant weight loss is defined as \>5% and \>10% of body weight at 30, 60, and 90 days after discharge. This will be calculated based on weight obtained during clinic visits.
Malnutrition - Low BMIat Baseline, 30, 60 and 90 daysLow BMI will be defined as \<20kg/m² for individuals \<70 years old and \<22kg/m2 for individuals ≥70 years old. This will be calculated based on weight and height measurements from clinic visits.
Malnutrition - Low Skeletal Muscle MassAt baseline, 30, 60 and 90 daysLow muscle mass will be estimated by calculating skeletal muscle index (SMI) from routinely collected CT scans at baseline and 90 days after discharge (CT scans are conducted every 3 months). Low muscle mass will be defined as SMI ≤38.9 cm2 /m2 for females and SMI ≤55.4 cm2 /m2 for males.
Quality of Lifeat Baseline, 4, 8 and 12 weeksQuality of Life will be measured using the Functional Assessment of Cancer Therapy - General (FACT-G) Questionnaire includes questions about the participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher score indicates a better quality of life.
Hospital Readmissions30, 60 and 90 days post-hospital dischargeHospital readmissions will be measured using a self-reported survey item to determine whether the patient was admitted to the index hospital or another hospital after hospital discharge.
Malnutrition -Nutritional Statusat Baseline, 30, 60 and 90 daysNutritional status will be measured using the Patient-Generated Subjective Global Assessment (PG-SGA) Short Form (score range: 0-35) and categorized based on a prior validation study (0-1 well nourished, 2-8 at-risk, = 9 severely malnourished).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKea Turner, PhD

Moffitt Cancer Center

PRINCIPAL_INVESTIGATORPamela J Hodul, MD

Moffitt Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026